Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: Infection control and molecular characterization

New Microbes and New Infections

Volumn 2, Issue 3, 2014, Pages 58-63

  Marquez, C ^a   Ingold, A ^b   Echeverria N ^b   Acevedo, A ^b   Vignoli, R ^c   Garcia Fulgueiras V ^c   Viroga, J ^d   Gonzalez, O ^d   Odizzio, V ^e   Etulain, K ^e   Nunez E ^d   Albornoz, H ^f   Borthagaray, G ^g   Galiana, A ^f  

^a Instituto de Química Biológica   (Uruguay)

^b Facultad de Química UdelaR   (Uruguay)

^c Universidad de la Republica Instituto de Higiene   (Uruguay)

^d Laboratorio Gram Microbiología   (Uruguay)

^e Sanatorio SEMM Mautone   (Uruguay)

^f HOSPITAL MACIEL   (Uruguay)

^g UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Antibiotic resistance; Infection control; KPC

Indexed keywords

CARBAPENEMASE; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TIGECYCLINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CASE REPORT; DISEASE PREDISPOSITION; DISK DIFFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; GENETIC ANALYSIS; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE INFECTION; LUNG INFECTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SALMONELLOSIS; SEPSIS; SEPTIC SHOCK; TRACHEOBRONCHITIS; VENTILATOR ASSOCIATED PNEUMONIA;

KLEBSIELLA PNEUMONIAE;

EID: 84916936754     PISSN: 20522975     EISSN: None     Source Type: Journal    
DOI: 10.1002/nmi2.40     Document Type: Article

References (26)

1. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012; 27: 128-142.
2. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP; Colombian Nosocomial Resistance Study Group. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem- hydrolyzing β-lactamase. Antimicrob Agents Chemother 2007; 51: 1553-1555.
3. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis 2006; 56: 367-372.
4. Gomez SA, Pasteran FG, Faccone D et al. Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin Microbiol Infect 2011; 17: 1520-1524.
5. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae in Brazil. Antimicrob Agents Chemother 2009; 53: 333-334.
6. Guerra SE, Albornoz H, Rosa R et al. Incidences of nosocomial infections in Uruguayan adult intensive care units 2010. International Conference on Prevention & Infection Control (ICPIC 2011), Geneva, Switzerland, 29 June-2 July 2011. BMC Proc 2011; 5(suppl 6): 77.
7. Centers for Diseases Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009; 58: 256-260.
8. Carmeli Y, Akova M, Cornaglia G et al. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16: 102-111.
9. CDC. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. Atlanta, GA: US Department of Health and Human Services, CDC, 2009.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st Informational Supplement. CLSI Document M100-S21. Wayne, PA: CLSI, 2011.
11. Clinical and Laboratory Standards Institute. Methods of dilution antimicrobial susceptibility test for bacteria that grow aerobically; Approved Standard 8th ed. CLSI Document M7-A8. Wayne, PA: CLSI, 2009.
12. Pasteran F, Lucero C, Rapoport M et al. Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae. J Infect Dev Ctries 2012; 6: 452-456.
13. Pournaras S, Kristo I, Vrioni G et al. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae. J Clin Microbiol 2010; 48: 2601-2604.
14. Ma L, Chang FY, Fung CP et al. Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist 2005; 11: 31-39.
15. Chowdhury PR, Ingold A, Vanegas N et al. Dissemination of multiple drug resistance genes by Class 1 integrons in Klebsiella isolates from four countries: a comparative study. Antimicrob Agents Chemother 2011; 557: 3140-3149.
16. Endimiani A, Carias LL, Hujer AM et al. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother 2008; 52: 2680-2682.
17. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-1798.
18. PER-2. Antimicrob Agents Chemother 2007; 51: 2359-2365.
19. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(b')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3953-3955.
20. Toleman MA, Bennett PM, Walsh TR. Common regions e.g orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. J Antimicrob Chemother 2006; 58: 1-6.
21. Lomaestro BM, Tobin EH, Shang W, Gootz T. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to Upstate New York. Clin Infect Dis 2006; 43: 26-28.
22. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
23. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetics structures at the origin of acquisitions of the b-lactamase blaKPC gene. Anitmicrob Agents Chemother 2008; 52: 1257-1263.
24. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 2011; 53: 49-56.
25. Nordmann P, Cuzon G, Nass T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236.
26. Kitchel B, Rasheed JK, Endimiani A, et al. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 4201-4207.